Who owns INVESTIGACIONES AVANZADAS EN FARMACOLOGIA AIE?

No ownership or control links for INVESTIGACIONES AVANZADAS EN FARMACOLOGIA AIE are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.

Where does INVESTIGACIONES AVANZADAS EN FARMACOLOGIA AIE appear across sources?

INVESTIGACIONES AVANZADAS EN FARMACOLOGIA AIE is indexed in the WhiteIntel corporate-ownership graph (ES), with a source on every claim.

LIVE · CORPUS

SnitchScore · reading…

evidence coverage · reading…

Coverage — measured

Sources fused: 1
Ownership hops held: 4

An absent edge means not yet observed — never does not exist.

Legal entityUnscored

INVESTIGACIONES AVANZADAS EN FARMACOLOGIA AIE

Name: INVESTIGACIONES AVANZADAS EN FARMACOLOGIA AIE — ownership dossier
Creator: WhiteIntel
License: https://whiteintel.dev/terms
Keywords: corporate ownership, beneficial ownership, UBO, corporate intelligence, OSINT, corporate registry, INVESTIGACIONES AVANZADAS EN FARMACOLOGIA AIE, Company, ES

INVESTIGACIONES AVANZADAS EN FARMACOLOGIA AIE — Spanish company (es-rm:M-814144). UBO chain traced 4 hops. Cited to 1 registry.

ES-RM M-814144Company

Ownership graph Export .md

JSON / MCPsample

The finding

Ownership resolves 4 hops deep toward the ultimate beneficial owner.

Investigative lead by resolved identity, not a legal determination.

/01

Ownership & control

Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.

No ownership or control links resolved yet

An absent link means “not yet observed in our current sources”, not that none exists — cross-source resolution is still growing.

Watch this entity

We flag the moment ownership, a filing or a sanctions signal lands on it — the fastest way to catch a change on a subject we hold little on today.

Where we look Report a lead Expand in the graph

Walk the full UBO chain

4 hops lockedSTANDARD

4-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.

Unlock Standard Dossier€39

Standard Dossier€39

The full ownership trace on this subject — every hop to the ultimate owner, its filing history and sanctions exposure — as PDF and JSON, every claim linked to its source.

Everything we hold on INVESTIGACIONES AVANZADAS EN FARMACOLOGIA AIE, resolved and sourced — yours to keep, no subscription.

INCLUDED WHEN YOU UNLOCK

UBO trace
Branded PDF + un-redacted JSON · every claim linked to its source
Re-download for 90 days

UBO trace

Guest checkout · email only · re-download 90 days. Or subscribe from €149.

WHAT YOU CAN SEEFREE

YOURS NOW · FREE

4 items you can read right now — no account, no payment.

Identity, address & registry profile
Sanctions & watchlist detail
Direct connections (1 hop)
Community notes

YOURS AFTER YOU UNLOCK · PAID

2 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.

Full ownership trace to the UBOSTANDARD
Full export (PDF + un-redacted JSON) & change alertsPREMIUM

/02

Registry movements

ADOSPHARMA SL → INVESTIGACIONES AVANZADAS EN FARMACOLOGIA AIE
Registry-recorded Member partner relationship, effective 20 Apr 2026.
20 Apr 2026
borme
I + MED SOCIEDAD COOPERATIVA → INVESTIGACIONES AVANZADAS EN FARMACOLOGIA AIE
Registry-recorded Member partner relationship, effective 20 Apr 2026.
20 Apr 2026
borme
ADASTRA VENTURES SL → INVESTIGACIONES AVANZADAS EN FARMACOLOGIA AIE
Registry-recorded Sole administrator relationship, effective 30 Dec 2025.
30 Dec 2025
borme
MOYA DENIA MARIO JOSE → INVESTIGACIONES AVANZADAS EN FARMACOLOGIA AIE
Registry-recorded Representative relationship, effective 30 Dec 2025.
30 Dec 2025
borme

/03

People & control

3 parties · 0 current

Every officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.

●
ADASTRA VENTURES SL
Also holds roles at 98 other companies
- AVANCES CIENTIFICOS EN BIOMEDICINA AIEJoint and several administrator
- POLIMEROS AVANZADOS PARA AUTOMOCION AIESole administrator
- LUR RESEARCH 2025 AIESole administrator
●
I + MED SOCIEDAD COOPERATIVA
Also holds roles at 1 other company
- TECNOLOGIA LLUCMAJOR AIEMember partner
●
MOYA DENIA MARIO JOSE
Also holds roles at 47 other companies
- TECNOLOGIAS DIGITALES AVANZADAS 2025 AIERepresentative
- ALIUS RESEARCH AIERepresentative
- ARX RESEARCH 2026 AIERepresentative

3 parties · 0 current. Ceased and resigned records are retained as history.

/04

Common questions

Who owns INVESTIGACIONES AVANZADAS EN FARMACOLOGIA AIE?: No ownership or control links for INVESTIGACIONES AVANZADAS EN FARMACOLOGIA AIE are resolved in the current sources yet — view the network graph to expand, or pull the cited JSON dossier.
What is INVESTIGACIONES AVANZADAS EN FARMACOLOGIA AIE's risk level?: INVESTIGACIONES AVANZADAS EN FARMACOLOGIA AIE has not yet been risk-scored — absence of a score means "not yet assessed", not "clean". Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership.
Where does INVESTIGACIONES AVANZADAS EN FARMACOLOGIA AIE appear across sources?: INVESTIGACIONES AVANZADAS EN FARMACOLOGIA AIE is indexed in the WhiteIntel corporate-ownership graph (ES), with a source on every claim.

Community intel

Crowd leads · unverified

Tips, corrections and leads contributed by the community on INVESTIGACIONES AVANZADAS EN FARMACOLOGIA AIE. These are unverified leads, not WhiteIntel findings — we surface them for investigators to chase, and analyse the corroborated ones into SnitchScore.

Loading tips…